| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/17/1997 | WO1997013855A1 Melanoma-associated protein |
| 04/17/1997 | WO1997013844A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | WO1997013841A1 Separation and concentration systems based on soluble oligosaccharide binding domains |
| 04/17/1997 | WO1997013785A1 Transferrin receptor protein of moraxella |
| 04/17/1997 | WO1997013784A1 Helicobacter lactoferrin receptor |
| 04/17/1997 | WO1997013531A1 Solid, orally administrable viral vaccines and methods of preparation |
| 04/17/1997 | WO1997013529A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 04/17/1997 | WO1997013523A1 Swine immunization using live, rtx toxin-secreting organisms |
| 04/17/1997 | WO1997013522A1 Generating d-peptides: methods and compositions |
| 04/17/1997 | WO1997008318A3 Compounds and methods for treatment and diagnosis of prostate cancer |
| 04/17/1997 | WO1997003203A3 Generation of immune responses to prostate-specific antigen (psa) |
| 04/17/1997 | WO1996030523A3 Antigen presentation system based on retrovirus-like particles |
| 04/17/1997 | DE19538641A1 Patientenspezifische Immunadsorber für die extrakorporale Apherese und Verfahren für deren Herstellung Patient-specific immuno for extracorporeal apheresis and methods for their preparation |
| 04/17/1997 | CA2599488A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | CA2234723A1 Generating d-peptides: methods and compositions |
| 04/17/1997 | CA2234666A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 04/17/1997 | CA2226785A1 Separation and concentration systems based on soluble oligosaccharide binding domains |
| 04/17/1997 | CA2207302A1 Neisseria meningitidis subunit tbp2 |
| 04/17/1997 | CA2206095A1 Recepteur lactoferrine d'helicobacter |
| 04/16/1997 | EP0768379A1 Ubiquitous potassium-channel proteins and genes for the same |
| 04/16/1997 | EP0767796A1 Monocyte chemotactic protein-4 |
| 04/16/1997 | EP0767678A1 Compositions of transactivating proteins of human immunodeficiency virus |
| 04/16/1997 | EP0767673A1 Methods for reduced renal uptake of antibody fragments |
| 04/16/1997 | EP0767667A2 USE OF $g(b)GalNac(1-4)$g(b)Gal CONJUGATES TO TREAT CANDIDA INFECTION |
| 04/16/1997 | EP0630259B1 Mycobacterium vaccae for treatment of long term autoimmune conditions |
| 04/16/1997 | EP0625912B1 Treatment for inflammatory bowel disease |
| 04/16/1997 | EP0514515B1 Anthracycline-conjugates |
| 04/16/1997 | EP0454782B1 Cancer related haptoglobin (hpr) |
| 04/16/1997 | CN1147834A Coordinate in vivo gene expression |
| 04/16/1997 | CN1147833A Hepatitis A virus culture process |
| 04/16/1997 | CN1147769A Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome |
| 04/16/1997 | CN1034569C Endothelin receptor antagonists |
| 04/16/1997 | CN1034554C Producing process for cell free marek's disease virus vaccine |
| 04/16/1997 | CN1034553C Avirulent microbes and uses therefor |
| 04/15/1997 | US5621081 Polypeptide; treatment of nervous system disorders |
| 04/15/1997 | US5621077 Genetic engineering |
| 04/15/1997 | US5621076 Poultry Mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same |
| 04/15/1997 | US5620956 Inhibiting differentiation of cytotoxic t-lymphocyte precursor to mature cell specific for foreign antigen |
| 04/15/1997 | US5620902 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 04/15/1997 | US5620896 Genetic engineering |
| 04/15/1997 | US5620889 Human anti-Fas IgG1 monoclonal antibodies |
| 04/15/1997 | US5620864 Acceptor for fucosyl transferase |
| 04/15/1997 | US5620862 Methods for diagnosing early Lyme disease |
| 04/15/1997 | US5620846 Diagnostic and prognostic indices for cancer and aids |
| 04/15/1997 | US5620844 Assays for detecting hepatitis B virus envelope antigens or antibodies thereto and diagnostic test kits for use in performing the assays |
| 04/15/1997 | US5620843 Non-A non-B sequences |
| 04/15/1997 | US5620691 Polypeptide vaccine |
| 04/15/1997 | US5620690 Immunogenic complexes |
| 04/15/1997 | US5620688 Methods of inhibiting the activation of Factor XIII |
| 04/15/1997 | US5620687 Inhibition of intimal hyperplasia using antibodies to PDGF beta receptors |
| 04/10/1997 | WO1997012984A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
| 04/10/1997 | WO1997012981A1 Rabies recombinant adenovirus |
| 04/10/1997 | WO1997012972A2 Regulated genes and uses thereof |
| 04/10/1997 | WO1997012969A2 Fmr1-related protein |
| 04/10/1997 | WO1997012910A1 Helicobacter pylori protein |
| 04/10/1997 | WO1997012909A1 Novel membrane proteins of helicobacter pylori |
| 04/10/1997 | WO1997012908A1 NOVEL MEMBRANE PROTEINE p76 OF HELICOBACTER PYLORI |
| 04/10/1997 | WO1997012907A1 Peptide inhibitor for viral protease derived from the transframe region of the gag-pol gene |
| 04/10/1997 | WO1997012901A1 Process for isolating immunoglobulins in whey |
| 04/10/1997 | WO1997012898A1 Novel platelet activation protein |
| 04/10/1997 | WO1997012633A1 Dendritic cell stimulatory factor |
| 04/10/1997 | WO1997005250A3 Receptor ligand vegf-c |
| 04/10/1997 | WO1996040764A3 Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus |
| 04/10/1997 | WO1996026961A3 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 04/10/1997 | CA2233994A1 Novel platelet activation protein |
| 04/10/1997 | CA2233983A1 Rabies recombinant adenovirus |
| 04/10/1997 | CA2233935A1 Process for isolating immunoglobulins in whey |
| 04/10/1997 | CA2233328A1 Helicobacter pylori protein |
| 04/10/1997 | CA2233296A1 Compound having sequence homology with lipoprotein associated phospholipase a2 (lp-pla2)/paf acetyl hydrolase |
| 04/10/1997 | CA2232865A1 The use of flt3 ligand to generate dendritic cells |
| 04/10/1997 | CA2230957A1 Regulated genes and uses thereof |
| 04/10/1997 | CA2206797A1 Novel membrane proteins of helicobacter pylori |
| 04/10/1997 | CA2206708A1 Novel membrane proteine p76 of helicobacter pylori |
| 04/09/1997 | EP0766967A1 Adjuvant complexes |
| 04/09/1997 | EP0766745A1 Monoclonal antibody specific for human 4-1bb and cell line producing same |
| 04/09/1997 | EP0766740A1 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
| 04/09/1997 | EP0766739A1 66 kDa ANTIGEN FROM BORRELIA |
| 04/09/1997 | EP0766693A1 Novel parasite protease genes and proteins |
| 04/09/1997 | EP0766569A1 Aav capsid vehicles for molecular transfer |
| 04/09/1997 | EP0766568A1 Method of isolating an antigene preparation |
| 04/09/1997 | EP0766567A1 METHODS AND COMPOSITIONS INCLUDING A 13 kD B. BURGDORFERI PROTEIN |
| 04/09/1997 | EP0766566A1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 04/09/1997 | EP0766565A1 Medical use of bromelain |
| 04/09/1997 | EP0766564A1 Controlled release polypeptide compositions and methods of treating inflammatory bowel disease |
| 04/09/1997 | EP0766512A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| 04/09/1997 | EP0667917B1 Evolutive vaccination |
| 04/09/1997 | EP0625911B1 Malaria treatments |
| 04/09/1997 | CN1147270A Method to identify immunocompromised patients at high risk for cryptococcosis |
| 04/09/1997 | CN1147259A Method of separating protective components of bordetella pertussis |
| 04/09/1997 | CN1147015A Marek's Disease Vaccine |
| 04/08/1997 | USRE35491 Methods and compositions for detecting human tumors |
| 04/08/1997 | US5618698 Growing host cells transformed or transfected with specified isolated dna sequence, isolating erythropoietin product |
| 04/08/1997 | US5618694 Tumor diagnosis |
| 04/08/1997 | US5618670 Detection method for c-raf-1 genes |
| 04/08/1997 | US5618542 Vaccines comprising antigenic polypeptides of Taenia ovis |
| 04/08/1997 | US5618541 Vaccine against Neisseria meningitidis infections |
| 04/08/1997 | US5618540 Subunit vaccine against Neisseria meningitidis infections and corresponding subunits in the purified state |
| 04/08/1997 | US5618539 Aqueous solution comprising a heat resist stabilizer lysine or/and arginine |
| 04/08/1997 | US5618536 Chimeric papillomavirus-like particles |
| 04/08/1997 | US5618534 Isolated antigen endo glyx-1 |